(Q30352753)

20 June 2017

1 reference

title

New trends in progressive multifocal leukoencephalopathy (English)

1 reference

progressive multifocal leukoencephalopathy

20 June 2017

main subject

0 references

author name string

Gasnault J

series ordinal

1

1 reference

20 June 2017

Taoufik Y

series ordinal

2

1 reference

20 June 2017

publication date

1 January 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

162

1 reference

20 June 2017

issue

1

1 reference

20 June 2017

page(s)

43-56

1 reference

Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Activities of various compounds against murine and primate polyomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain are unique derivatives of a single archetypal structure

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive BK virus associated multifocal leukoencephalopathy in an immunocompromised patient treated with corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Immunorestitution disease involving the innate and adaptive response

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Persistence of DNA Sequences of BK Virus and JC Virus in Normal Human Tissues and in Diseased Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Diagnosis of central nervous system complications in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The Effect of Highly Active Antiretroviral Therapy-Induced Immune Reconstitution on Development and Outcome of Progressive Multifocal Leukoencephalopathy: Study of 43 Cases with Review of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The Evolving Face of Human Immunodeficiency Virus-Related Progressive Multifocal Leukoencephalopathy: Defining a Consensus Terminology

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Challenges for Clinical Trials to Treat Progressive Multifocal Leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Changing incidence of central nervous system diseases in the EuroSIDA cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Association of human polyomavirus JC with peripheral blood of immunoimpaired and healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The human polyomavirus, JCV, uses serotonin receptors to infect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Increased frequency of JC virus type 2 and of dual infection with JC virus type 1 and 2 in Italian progressive multifocal leukoencephalopathy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The changing pattern of HIV neuropathology in the HAART era.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy: simultaneous detection of JCV DNA and anti-JCV antibodies in the cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy (PML) in chronic lymphatic leukemia (CLL). Review of the literature and case report

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue: Report of a case with unusual light and electron microscopic features

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Inhibition of human neurotropic virus (JCV) DNA replication in glial cells by camptothecin

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Human neurotropic polyomavirus, JCV, and its role in carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Oligosaccharides as receptors for JC virus

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Cellular changes in the cerebellar granular layer in AIDS-associated PML.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy (PML) in the acquired immunodeficiency syndrome (AIDS). A neuropathological autopsy study of 21 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML).

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Glial cells of the human developing brain and B cells of the immune system share a common DNA binding factor for recognition of the regulatory sequences of the human polyomavirus, JCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Lineage pathway of human brain progenitor cells identified by JC virus susceptability

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive Multifocal Leukoencephalopathy in a Male Homosexual with T-Cell Immune Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus detection by in situ hybridization in brain tissue from elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

AIDS- and non-AIDS-related PML association with distinct p53 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy: A burnt-out case

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Transcriptional regulation: lessons from the human neurotropic polyomavirus, JCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Glial cells as targets of viral infection in the human central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Low prevalence of Progressive Multifocal Leukoencephalopathy in India and Africa: Is There a Biological Explanation?

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Multiple malignant astrocytomas in a patient with spontaneous progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Cortical and subcortical JC virus infection: two unusual cases of AIDS associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Cerebellar degeneration associated with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Prognostic value of JC virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in AIDS: a clinicopathologic study and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Human polyomavirus JC virus genome

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Progressive multifocal leukoencephalopathy and gliomas in a HIV-negative patient

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Changing patterns in the neuropathogenesis of HIV during the HAART era.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0035-3787%2806%2974981-5

7 January 2021

10.1016/S0035-3787(06)74981-5

Identifiers

DOI

1 reference

20 June 2017

1 reference